For example, in hepatocellular carcinoma, JQ1 alone increased PD-L1 via Rab8A, but combining JQ1 with anti-PD-L1 restored cytotoxicity and reduced tumor progression (145). Here, CD274 is linked to hepatocellular carcinoma.